ECigIntelligence Interview: Stricter Regulation on NGPs, Especially in Nicotine Pouches

2Firsts Events by 2FIRSTS, edited by Sophia
Sep.20.2024
ECigIntelligence Interview: Stricter Regulation on NGPs, Especially in Nicotine Pouches
At InterTabac, Pablo, the legal analysis director from ECigIntelligence, stated in a conversation with 2Firsts that the global trend towards reducing tobacco harm reduction is strengthening, leading to increasingly strict regulation of NGPs. He pointed out that brands need to be prepared to face this pressure, especially in the field of nicotine pouches.

On September 19th, the InterTabac officially opened in Germany. As the official media partner, 2Firsts arrived at the event and had a discussion with Pablo Cano Trilla, the Head of Legal Analysis from ECigIntelligence.

 

TobaccoIntelligence is a professional tobacco consulting company based in Spain, with a sister company focused on the e-cigarette industry called ECigIntelligence. Both are independent brands operated by the same parent company, Tamarind Intelligence. At the industry conference during this expo, Pablo represented ECigIntelligence and delivered a speech titled "Legal Challenges, Prospects and Future Projections in the Evolving Nicotine and Novel Tobacco Sectors."

 

After the speech, Pablo discussed with 2Firsts that globally, there is a growing trend of reducing harm from tobacco, leading to increasingly strict regulations on new tobacco products. He pointed out that brands need to be prepared to face this pressure, especially in the area of nicotine pouches. 

 

He emphasized that the most likely scenario is that nicotine pouches are not going to be banned, but this is not something that should be discarded.

 

ECigIntelligence Interview: Stricter Regulation on NGPs, Especially in Nicotine Pouches
Pablo speaks at a lecture | Image source: 2Firsts

 

NGPs face strict regulation, nicotine pouches may be banned

 

As the head of legal analysis at a professional tobacco consulting company, Pablo states that 2024 will be a crucial turning point for EU regulation of new tobacco products, particularly in the regulation of emerging products such as nicotine pouches. Pablo anticipates that the revised Tobacco Products Directive (TPD) will introduce more uniform rules, covering pre-market approval, advertising restrictions, and environmental regulations for products like nicotine pouches.

 

He emphasized that nicotine pouches have become a new target for regulation. Whether they will be banned or not remains uncertain. Nicotine pouch manufacturers and sellers need to closely monitor policy changes to ensure their products meet new regulatory requirements and adapt to the constantly evolving market environment.

 

Furthermore, Pablo told 2Firsts that European policymakers are paying particular attention to the regulation of e-vapor products (EVP), with a decreasing demand for disposable e-cigarettes in the European market (especially in the UK, Germany, and France) and a shift towards refillable products becoming the new mainstream. He mentioned that policies such as flavor bans for disposable products not only affect the European market but may also have a ripple effect on other regions, such as Brazil in Latin America.

 

ECigIntelligence Interview: Stricter Regulation on NGPs, Especially in Nicotine Pouches
Pablo's speech content │ Image source: 2Firsts

 

Taste preferences for nicotine pouches vary between Europe and US, with potential in the Latin America

 

Pablo mentioned to 2Firsts that there are certain differences between the European and American markets in terms of nicotine pouch flavor preferences.

 

For example, in the fourth quarter of 2023, he pointed out that consumers in Europe and America both prefer nicotine pouch products with a cool sensation flavor.

 

In Europe, consumers have a greater preference for nicotine pouches in "fruit" and "mixed" flavors. In the fourth quarter of 2023, the market share of "fruit" nicotine pouches reached 27%, while "mixed" flavors reached 24%.

 

In the emerging e-cigarette market, Pablo believes that Latin America has tremendous market potential. Despite Southeast Asia being a hot spot in the industry, increasingly strict regulations have made its market prospects less clear. Additionally, the launch of proprietary brand products by China Tobacco (CNTC) at the trade show demonstrates China's significant position in the global tobacco industry, warranting industry attention.

 

ECigIntelligence Interview: Stricter Regulation on NGPs, Especially in Nicotine Pouches
Pablo's speech content │ Image source: 2Firsts

 

Prediction: HTP, EVP, and OND facing different opportunities

 

Pablo predicts that HNB tobacco products (HTP), e-cigarette vapor products (EVP), and nicotine pouches (OND) will face different growth opportunities in 2025.

 

He believes that HNB products will experience rapid growth, especially in markets such as the Middle East and North America, as well as in European countries such as Italy, and Spain.

 

According to forecasts from Pablo, e-cigarette vapor products have huge market potential in Latin America. Nicotine pouches have become very popular in European and American markets, especially the brand represented by ZYN has achieved significant success in the US market.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Four CrossBar 20K disposable e-cigarettes appeared on Pennsylvania's 163-entry ENDS directory ahead of enforcement beginning October 19, 2026. The devices feature 13mL e-liquid reservoirs, 50mg/mL nicotine, 2,000mAh batteries and 0.9Ω mesh coils, with advertised puff counts of up to 20,000. CrossBar was the only modern high-puff disposable series among the directory's 15 disposable entries. Its packaging emphasizes New York design and Japanese-origin flavoring, while historical CrossBar records identify a registered U.S. tobacco manufacturing-related establishment. The link between the newer 13mL devices and earlier 1.3mL PMTA filings remains unconfirmed.
product
Oct.26
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11
Major U.S.  Vape Distributor Demand Vape Pays at Least $300,000 for White House Lobbying Amid Enforcement Pressure
Major U.S. Vape Distributor Demand Vape Pays at Least $300,000 for White House Lobbying Amid Enforcement Pressure
New York vape distributor Ecto World, which operates as Demand Vape, hired political consultant Roger Stone to lobby the Executive Office of the President on regulation of vaping and related products while facing state enforcement and multiple lawsuits. Public lobbying disclosures show that Ecto World paid at least $300,000 for the work through June 30, 2026. Separately, New York State announced in March that more than 28,500 pounds of vaping products tied to the company had been seized, while New York City and the state have pursued legal or enforcement actions. Public records do not show that the lobbying directly changed any specific regulatory or enforcement outcome.
Sep.08
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana's Alcohol and Tobacco Commission (ATC) ordered tobacco certificate holders in September to remove certain vaping products marketed under Elf Bar, Lost Mary, MR FOG, iJOY and other brands from inventory under the state's foreign-adversary product law. The agency later listed 257 MR FOG products and 77 Lost Mary product entries as lawful for sale. The Lost Mary revision expressly stated that compliance evidence had been received for 20 additional products. 2Firsts compliance expert Kurt said potential filings could include e-liquid and ingredient-origin records, U.S. nicotine-analog supply-chain documentation and FDA premarket application status.
Regulations
Oct.08
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25